Neogen (NEOG) Competitors $5.47 -0.03 (-0.55%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$5.45 -0.02 (-0.38%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEOG vs. ICUI, XRAY, HAE, QDEL, STAA, CERS, OSUR, UTMD, ANIK, and WSTShould you be buying Neogen stock or one of its competitors? The main competitors of Neogen include ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), and West Pharmaceutical Services (WST). These companies are all part of the "health care supplies" industry. Neogen vs. Its Competitors ICU Medical DENTSPLY SIRONA Haemonetics QuidelOrtho STAAR Surgical Cerus OraSure Technologies Utah Medical Products Anika Therapeutics West Pharmaceutical Services Neogen (NASDAQ:NEOG) and ICU Medical (NASDAQ:ICUI) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings. Which has stronger earnings and valuation, NEOG or ICUI? ICU Medical has higher revenue and earnings than Neogen. ICU Medical is trading at a lower price-to-earnings ratio than Neogen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeogen$894.66M1.33-$1.09B-$5.03-1.09ICU Medical$2.38B1.37-$117.69M-$1.52-86.95 Do analysts rate NEOG or ICUI? Neogen currently has a consensus price target of $7.50, indicating a potential upside of 37.11%. ICU Medical has a consensus price target of $181.00, indicating a potential upside of 36.94%. Given Neogen's higher probable upside, research analysts clearly believe Neogen is more favorable than ICU Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neogen 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25ICU Medical 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more volatility and risk, NEOG or ICUI? Neogen has a beta of 1.84, meaning that its share price is 84% more volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Do institutionals & insiders believe in NEOG or ICUI? 96.7% of Neogen shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 1.1% of Neogen shares are held by company insiders. Comparatively, 1.5% of ICU Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is NEOG or ICUI more profitable? ICU Medical has a net margin of -1.56% compared to Neogen's net margin of -122.06%. ICU Medical's return on equity of 7.24% beat Neogen's return on equity.Company Net Margins Return on Equity Return on Assets Neogen-122.06% 2.39% 1.57% ICU Medical -1.56%7.24%3.50% Does the media refer more to NEOG or ICUI? In the previous week, Neogen had 18 more articles in the media than ICU Medical. MarketBeat recorded 34 mentions for Neogen and 16 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.12 beat Neogen's score of 0.28 indicating that ICU Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neogen 5 Very Positive mention(s) 1 Positive mention(s) 25 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral ICU Medical 8 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryICU Medical beats Neogen on 12 of the 17 factors compared between the two stocks. Get Neogen News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEOG vs. The Competition Export to ExcelMetricNeogenMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.19B$10.74B$5.80B$10.16BDividend YieldN/A1.86%5.72%4.60%P/E Ratio-1.0920.5675.1326.39Price / Sales1.3329.77508.32174.86Price / Cash0.9525.0025.8129.91Price / Book0.573.4313.716.28Net Income-$1.09B$210.63M$3.29B$270.38M7 Day Performance-4.54%-1.46%0.07%1.89%1 Month Performance0.74%1.65%4.57%6.01%1 Year Performance-66.52%-11.43%78.24%25.26% Neogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEOGNeogen3.2712 of 5 stars$5.47-0.5%$7.50+37.1%-66.1%$1.19B$894.66M-1.092,110ICUIICU Medical4.6115 of 5 stars$130.58-0.5%$179.00+37.1%-26.2%$3.24B$2.38B-85.9115,000Positive NewsXRAYDENTSPLY SIRONA4.9145 of 5 stars$14.21-2.8%$18.64+31.1%-48.5%$2.92B$3.79B-3.0014,000Positive NewsHAEHaemonetics4.8843 of 5 stars$54.02-0.7%$85.18+57.7%-32.5%$2.62B$1.35B16.523,023QDELQuidelOrtho4.3265 of 5 stars$28.47-0.7%$39.20+37.7%-36.4%$1.95B$2.78B-4.356,600Positive NewsSTAASTAAR Surgical2.6511 of 5 stars$27.69-0.9%$20.67-25.4%-14.5%$1.38B$313.90M-14.351,211CERSCerus3.0925 of 5 stars$1.30-2.3%$3.50+169.2%-42.0%$254.96M$180.27M-13.00290News CoverageShort Interest ↓OSUROraSure Technologies1.9114 of 5 stars$3.25+0.6%$3.00-7.7%-27.4%$236.23M$185.83M-4.85840UTMDUtah Medical Products3.0304 of 5 stars$63.35-0.1%N/A-8.1%$203.24M$40.90M16.95180Positive NewsANIKAnika Therapeutics4.3491 of 5 stars$8.94flat$18.00+101.3%-64.9%$128.90M$114.55M-2.15300WSTWest Pharmaceutical Services4.9783 of 5 stars$253.30+1.0%$320.71+26.6%-14.3%$18.03B$2.89B37.9210,600News CoveragePositive NewsAnalyst Forecast Related Companies and Tools Related Companies ICUI Competitors XRAY Competitors HAE Competitors QDEL Competitors STAA Competitors CERS Competitors OSUR Competitors UTMD Competitors ANIK Competitors WST Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NEOG) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neogen Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Neogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.